Seelos Therapeutics Inc (SEEL)

[casinokid11211]

Just one very, very,very,very, minor detail

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
On June 2, 2016, Apricus Biosciences, Inc. (the “Company”) received a notice from the NASDAQ Listing Qualifications Staff that the Company no
longer satisfies the minimum $35 million market value of listed securities requirement as required for continued listing on The NASDAQ Capital Market
under NASDAQ Listing Rule 5550(b)(2). However, in accordance with the NASDAQ Listing Rules, the Company has been granted a 180-day period within
which to regain compliance with the market capitalization requirements, through November 29, 2016. In order to achieve compliance, the Company must
evidence a market value of listed securities of at least $35 million for a minimum of 10 consecutive business days. The notice has no immediate effect on the
listing or trading of the Company’s common stock and the common stock will continue to trade on The NASDAQ Capital Market under the symbol “APRI.”